Even though sharing data could be extremely beneficial for research, Waldstreicher stated that there is still "a bit of a learning process." For example, in trials that recruited patients with rare diseases, anonymity could be jeopardized.
http://www.counselheal.com/articles/8514/20140201/johnson-johnson-will-release-clinical-data-to-researchers.htm
From My iPhone